Option Care Health, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John C. Rademacher
- Full Time Employees
- 7,397
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 3000 Lakeside Drive Bannockburn IL United States of America 60015
- IPO Date
- Aug 15, 1996
- CIK
- 0001014739
- Website
- optioncarehealth.com
- Similar Companies
- Business
- Option Care Health, Inc. (OPCH) is the nation's largest independent provider of home and alternate site infusion services in the United States, delivering clinical management and customized infusion therapies; anti-infective therapies; heart failure therapies including inotropes; chronic inflammatory disorders such as rheumatoid arthritis, Crohn's disease and ulcerative colitis; immunoglobulin therapies for primary immunodeficiency disorders; bleeding disorder therapies including hemophilia; neurological disorders including multiple sclerosis; and other therapies for nutrition support, bleeding disorders and alpha-1 antitrypsin deficiency; as well as specialty pharmacy services distributing over 50 limited-distribution drugs across its national network of more than 90 full-service pharmacies and 180 ambulatory infusion suites. Founded in 1979 and headquartered in Bannockburn, Illinois, the company serves patients nationwide through partnerships with healthcare providers, hospitals, health systems, pharmaceutical manufacturers and major insurance payers, focusing on acute and chronic conditions to optimize outcomes, reduce readmissions and lower costs with 24/7 support. Recent developments include a strategic partnership with Quince Therapeutics announced in August 2025 to serve as specialty infusion provider for eDSP administration in ataxia-telangiectasia and other indications pending regulatory approval; expansion of its collaboration with WellSky to implement CareTend platform enhancements across over 160 locations for improved pharmacy operations and patient care; and the acquisition of Intramed Plus, a South Carolina-based infusion provider, completed in January 2025 to bolster its regional footprint.
OPCH vs. PNTG: Which Stock Is the Better Value Option?
Is Option Care Health (OPCH) Stock Undervalued Right Now?
Amundi Sells 38,525 Shares of Option Care Health, Inc. $OPCH
Option Care Health, Inc. (OPCH) Q2 2026 Earnings Call Transcript
Option Care Health Q2 Earnings Call Highlights
Option Care (OPCH) Beats Q2 Earnings and Revenue Estimates
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
Dimensional Fund Advisors LP Buys 36,208 Shares of Option Care Health, Inc. $OPCH
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
A Look at Option Care Health Inc (OPCH) After 3.2% Decline -- GF Value $40.10 vs Price $20.88
OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.
OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.
Securities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Option Care Health, Inc. (OPCH) Shareholders Who Lost Money -- Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Option Care Health, Inc. (OPCH) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Option Care Health, Inc. (OPCH) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Option Care Health (OPCH) Securities Fraud Investigation - Levi & Korsinsky
OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc.